ClassID:

21437

A61K49/0058 - page 2 - CPC Classification

Classification description:

Preparations for testing; Preparation for luminescence or biological staining; Luminescence; Fluorescence characterised by the carrier molecule carrying the fluorescent agent Antibodies

Recent Application in this class:
#301
20160349266
2016-12-01

Fluoroimmunoassay Method

#302
20160349251
2016-12-01

Use of fluorescence for the quick and easy determination of s-adenosylmethionine, s-adenosylhomocysteine and homocysteine

#303
20160347840
2016-12-01

Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof

#304
20160347831
2016-12-01

Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof

#305
20160345834
2016-12-01

Methods of treating and imaging tumor micrometastases using photoactive immunoconjugates

#306
20160339113
2016-11-24

Microvessel endothelial cell surface markers and uses thereof

#307
20160326240
2016-11-10

Isolated monoclonal anti-repulsive guidance molecule A antibodies and uses thereof

#308
20160319019
2016-11-03

Anti-PD-1 antibodies

#309
20160311903
2016-10-27

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof

#310
20160304562
2016-10-20

Cell penetrating protein adaptor molecules and their application in research and medicine

#311
20160289324
2016-10-06

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

#312
20160272703
2016-09-22

TNF-ALPHA BINDING PROTEINS

#313
20160264651
2016-09-15

ANTI-TENASCIN-C A2 ANTIBODIES AND METHODS OF USE

#314
20160252530
2016-09-01

Methods for treating spinocerebellar ataxia type I using RPA1

#315
20160251436
2016-09-01

Anti-PD-1 antibodies

#316
20160251417
2016-09-01

ANTIBODIES RECOGNIZING MEDIN

#317
20160251416
2016-09-01

Humanized antibodies that recognize alpha-synuclein

#318
20160250342
2016-09-01

Hydrazinyl-indole compounds and methods for producing a conjugate

#319
20160237160
2016-08-18

ANTI-TWEAKR ANTIBODIES AND USES THEREOF

#320
20160229919
2016-08-11

Mesothelin domain-specific monoclonal antibodies and use thereof

#321
20160222110
2016-08-04

FC RECEPTOR BINDING PROTEINS

#322
20160215064
2016-07-28

Antibodies specific for urokinase-type plasminogen activator and methods of use thereof

#323
20160208008
2016-07-21

MONOCLONAL ANTIBODIES TO TRANSFERRIN AND TRANSFERRIN RECEPTOR ANTIGENS, AND USES THEREOF

#324
20160207999
2016-07-21

Anti-human folate receptor beta antibodies and methods of use

#325
20160200826
2016-07-14

Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof

#326
20160199524
2016-07-14

RADIOSENSITIVITY OF FLUOROPHORES AND USE OF RADIOPROTECTIVE AGENTS FOR DUAL-MODALITY IMAGING

#327
20160199033
2016-07-14

Method for quantifying the characteristics of an object treated with a contrast agent

#328
20160194388
2016-07-07

Monoclonal antibodies to human 14-3-3 epsilon and human 14-3-3 epsilon sv

#329
20160193332
2016-07-07

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

#330
20160184459
2016-06-30

CANCER CELL SPECIFIC IMAGING PROBES AND METHODS OF USE

#331
20160152725
2016-06-02

ANTIGEN-BINDING PROTEINS SPECIFIC FOR HLA-A2-RESTRICTED WILMS TUMOR 1 PEPTIDE

#332
20160130358
2016-05-12

Cysteine engineered antibodies and conjugates

#333
20160122416
2016-05-05

Antibody composition and buffer system therefor

#334
20160121002
2016-05-05

Bioorthogonal turn-on probes

#335
20160067358
2016-03-10

TUMOR SPECIFIC ANITBODY CONJUGATES AND USES THEREFOR

#336
20160060356
2016-03-03

Anti-FAP antibodies and methods of use

#337
20160045622
2016-02-18

IN VIVO CELL IMAGING

#338
20160038602
2016-02-11

Compounds and methods for producing a conjugate

#339
20160030595
2016-02-04

Method of treating cancer by administering chimeric antigen receptor comprising anti-GCC antibody

#340
20160009823
2016-01-14

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

#341
20150374308
2015-12-31

Method and apparatus for medical imaging using differencing of multiple fluorophores

#342
20150359905
2015-12-17

Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases

#343
20150352230
2015-12-10

SYNTHESIS AND ISOLATION OF DENDRIMER BASED IMAGING SYSTEMS

#344
20150343087
2015-12-03

Class I anti-CEA antibodies and uses thereof

#345
20150322078
2015-11-12

Benzopyrylium compounds

#346
20150309039
2015-10-29

Polymeric carriers for immunohistochemistry and in situ hybridization

#347
20150306254
2015-10-29

Anti-C3d antibody conjugates and methods of detecting complement activation

#348
20150238637
2015-08-27

Blood-brain Barrier Epitopes and Uses Thereof

#349
20150202331
2015-07-23

Sulfonic esters of metal oxides and methods of their use

#350
20150182644
2015-07-02

Compounds and methods for the detection of TRPV-6 cancers and drug delivery

#351
20150174274
2015-06-25

Modulation of immunity and CEACAM1 activity

#352
20150166791
2015-06-18

FLUORESCENT POLYMETHINE CYANINE DYES

#353
20150166674
2015-06-18

Antibodies and immunoconjugates and uses therefor

#354
20150165076
2015-06-18

Anti-mucin antibodies for early detection and treatment of pancreatic cancer

#355
20150150912
2015-06-04

CEACAM1 mediated protective immunity

#356
20150125397
2015-05-07

DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IMMUNE CELL RECEPTORS AND AUTOANTIGENS

#357
20150119553
2015-04-30

Bioconjugates of cyanine dyes

#358
20150118156
2015-04-30

Antibodies that bind to repulsive guidance molecule A (RGMA)

#359
20150111279
2015-04-23

Class I anti-CEA antibodies and uses thereof

#360
20150110798
2015-04-23

Anti-human folate receptor beta antibodies and methods of use

#361
20150110720
2015-04-23

Fluorescent fusion polypeptides and methods of use

#362
20150105619
2015-04-16

LIGHT EMITTING DIODE ENDOSCOPIC DEVICES FOR VISUALIZATION OF DISEASED TISSUE IN HUMANS AND ANIMALS

#363
20150079002
2015-03-19

In-vivo reactive species imaging

#364
20150056133
2015-02-26

CX3CR1-targeting imaging agents and their use in the diagnosis and treatment of disease

#365
20140377174
2014-12-25

Method for preparing cell targeting conjugates, and the complexes obtained

#366
20140371429
2014-12-18

Methods and composition for secretion of heterologous polypeptides

#367
20140363373
2014-12-11

METHOD FOR COMBINED IMAGING AND TREATING ORGANS AND TISSUES

#368
20140342374
2014-11-20

Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof

#369
20140341810
2014-11-20

ANTAGONISTS FOR ABDOMINAL VASOPRESSIN V2 RECEPTOR AND USES THEREOF

#370
20140316186
2014-10-23

Antibodies to TIP-1

#371
20140308278
2014-10-16

Class I anti-CEA antibodies and uses thereof

#372
20140271470
2014-09-18

TARGETED THERANOSTICS FOR METASTATIC PROSTATE CANCER

#373
20140255313
2014-09-11

Compositions and methods for detecting protease activity in biological systems

#374
20140243236
2014-08-28

Polymeric carriers for immunohistochemistry and in situ hybridization

#375
20140193830
2014-07-10

Optical biosensors

#376
20140178299
2014-06-26

Methods and compositions for detection of cancer

#377
20140141025
2014-05-22

Hydrazinyl-indole compounds and methods for producing a conjugate

#378
20140099265
2014-04-10

METHOD FOR AVIAN SEX DETERMINATION

#379
20140093458
2014-04-03

IN VIVO SELECTION OF THERAPEUTICALLY ACTIVE ANTIBODIES

#380
20140030193
2014-01-30

CUINSE/ZNS NIR-QUANTUM DOTS (QDS) FOR BIOMEDICAL IMAGIING

#381
20140017174
2014-01-16

METHODS AND COMPOSITIONS FOR DETERMINING RESPONSIVENESS TO TREATMENT WITH A TNF-ALPHA INHIBITOR

#382
20130336995
2013-12-19

Photosensitizing antibody-fluorophore conjugates

#383
20130323180
2013-12-05

Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label

#384
20130316402
2013-11-28

Antibodies and immunoconjugates and uses therefor

#385
20130315923
2013-11-28

Anti-GCC antibody molecules

#386
20130315906
2013-11-28

Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

#387
20130315840
2013-11-28

COMPOUND

#388
20130315834
2013-11-28

NANOPROBE COMPRISING GOLD COLLOID NANOPARTICLES FOR MULTIMODALITY OPTICAL IMAGING OF CANCER AND TARGETED DRUG DELIVERY FOR CANCER

#389
20130309257
2013-11-21

Thiazolidine linker for the conjugation of drugs to antibodies

#390
20130287702
2013-10-31

Methods and compositions for the detection of cancer cells

#391
20130287701
2013-10-31

METHOD OF DETECTING RISK OF CANCER

#392
20130280172
2013-10-24

Fluorescent imaging with substituted cyanine dyes

#393
20130273565
2013-10-17

Polymeric carriers for immunohistochemistry and in situ hybridization

#394
20130230521
2013-09-05

Tumor-targeting monoclonal antibodies to FZD10 and uses thereof

#395
20130230465
2013-09-05

Benzocyanine compounds

#396
20130230464
2013-09-05

Imaging probe including nanoparticle

#397
20130224120
2013-08-29

Multimodal diagnostic technology for early stage cancer lesions

#398
20130209365
2013-08-15

Anti-C-met antibody and methods of use thereof

#399
20130177570
2013-07-11

Anti-human folate receptor beta antibodies and methods of use

#400
20130171074
2013-07-04

TARGETING COMPOUNDS

#401
20130171061
2013-07-04

Anti-human transferrin receptor antibody and uses thereof

#402
20130129619
2013-05-23

Molecular imaging of cancer cells in vivo

#403
20130101517
2013-04-25

Development of photostable near-IR cyanine dyes for in vivo imaging

#404
20130064763
2013-03-14

Anti-ICAM-1 single domain antibody and uses thereof

#405
20130045488
2013-02-21

Benzocyanine compounds

#406
20130045220
2013-02-21

Microvesicle membrane protein and application thereof

#407
20130045218
2013-02-21

FC RECEPTOR BINDING PROTEINS

#408
20130039860
2013-02-14

Fluorescent imaging with substituted cyanine dyes

#409
20130034554
2013-02-07

Subcutaneously administrable composition containing anti-IL-6 antibody

#410
20130034492
2013-02-07

Class I anti-CEA antibodies and uses thereof

#411
20130028860
2013-01-31

Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity

#412
20120294852
2012-11-22

ANTAGONISTS OF IL-6 TO RAISE ALBUMIN AND/OR LOWER CRP

#413
20120288512
2012-11-15

Anti-CD70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders

#414
20120288504
2012-11-15

Antagonists of IL-6 to prevent or treat thrombosis

#415
20120288442
2012-11-15

Nuclear Imaging Method Using Molecular Target Detection Agent for Liver Fibrosis

#416
20120282280
2012-11-08

Bi-specific digoxigenin binding antibodies

#417
20120270338
2012-10-25

FLUOROIMMUNOASSAY METHOD

#418
20120269723
2012-10-25

Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent

#419
20120269721
2012-10-25

TARGETED NANOCLUSTERS AND METHODS OF THEIR USE

#420
20120263647
2012-10-18

Pro104 Antibody Compositions and Methods of Use

#421
20120253160
2012-10-04

Methods and Reagents for in Vivo Imaging of Cancel Cell Lines

#422
20120251559
2012-10-04

Treatment of B-cell cancers with anti-CD70 antibody-drug conjugates

#423
20120230911
2012-09-13

TNF-α binding proteins

#424
20120226119
2012-09-06

VIVO TUMOR VASCULATURE IMAGING

#425
20120195892
2012-08-02

Immunoglobulin molecules with improved characteristics

#426
20120190925
2012-07-26

METHOD FOR COMBINED IMAGING AND TREATING ORGANS AND TISSUES

#427
20120184050
2012-07-19

Multiplex screening for lysosomal storage disorders (LSDS)

#428
20120156283
2012-06-21

Methods and compositions for wound treatment

#429
20120148580
2012-06-14

Methods for identification of sites for IgG conjugation

#430
20120135459
2012-05-31

Fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques

#431
20120114704
2012-05-10

Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases

#432
20120107243
2012-05-03

PEPTIDE-MEDIATED NON-COVALENT DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER

#433
20120107233
2012-05-03

Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44

#434
20120095387
2012-04-19

METHODS FOR DETECTION, DIAGNOSIS AND SELECTIVE ERADICATION OF NEOPLASMS IN VIVO USING MULTIDOMAIN BIOTAGS

#435
20120093733
2012-04-19

MULTIDOMAIN BIOTAGS FOR CANCER DETECTION, DIAGNOSIS AND THERAPY AND METHODS OF THEIR USE

#436
20120089137
2012-04-12

Method and composition for hyperthermally treating cells

#437
20120089017
2012-04-12

LIGANDS TO RADIATION-INDUCED MOLECULES

#438
20120087860
2012-04-12

METHODS FOR IN VIVO CANCER DETECTION, DIAGNOSIS AND THERAPY USING MULTIDOMAIN BIOTAGS

#439
20120083761
2012-04-05

METHODS FOR SELECTIVE ERADICATION OF METASTASIZING CANCER CELLS EX VIVO USING MULTIDOMAIN BIOTAGS

#440
20120083005
2012-04-05

METHODS FOR IN VITRO CANCER CELL DETECTION, DIAGNOSIS AND THERAPY USING MULTIDOMAIN BIOTAGS

#441
20120058052
2012-03-08

METHOD FOR AVIAN SEX DETERMINATION

#442
20120045391
2012-02-23

Formulations targeting IGFBP7 for diagnosis and therapy of cancer

#443
20120039807
2012-02-16

Anti-tenascin-C A2 antibodies and methods of use

#444
20120010558
2012-01-12

Photosensitizing antibody-fluorophore conjugates

#445
20110288278
2011-11-24

Diagnostic agent and therapeutic agent for pancreatic cancer

#446
20110287035
2011-11-24

Method and composition for hyperthermally treating cells

#447
20110286973
2011-11-24

METHODS FOR INTRODUCING HETEROLOGOUS CELLS INTO FISH

#448
20110280881
2011-11-17

NOVEL ANTI-HSP90 MONOCLONAL ANTIBODY

#449
20110268661
2011-11-03

Fluorescent fusion polypeptides and methods of use

#450
20110268657
2011-11-03

Compositions and methods for the treatment of tumor of hematopoietic origin

#451
20110250283
2011-10-13

Pentablock polymers

#452
20110250210
2011-10-13

Neutralizing antibodies and fragments thereof directed against platelet factor-4 variant 1 (PF4V1)

#453
20110245098
2011-10-06

Polymeric carriers for immunohistochemistry and in situ hybridization

#454
20110244545
2011-10-06

Polymeric carriers for immunohistochemistry and in situ hybridization

#455
20110244544
2011-10-06

Polymeric carriers for immunohistochemistry and in situ hybridization

#456
20110237909
2011-09-29

Systems, Circuits and Apparatus For In Vivo Detection of Biomolecule Concentrations Using Fluorescent Tags

#457
20110230761
2011-09-22

Method and composition for hyperthermally treating cells

#458
20110182816
2011-07-28

Antibody against oxidized LDL/βGPI complex and use of the same

#459
20110171124
2011-07-14

In situ methods for monitoring the EMT status of tumor cells in vivo

#460
20110171122
2011-07-14

Methods and compositions for the detection of cancer

#461
20110165072
2011-07-07

Detection of early-stage pancreatic adenocarcinoma

#462
20110159519
2011-06-30

Optical biosensors

#463
20110150908
2011-06-23

Anti-CD70 antibody-drug conjugates and their use for the treatment and prevention of cancer and immune disorders

#464
20110123552
2011-05-26

Agonistic binding molecules to the human OX40 receptor

#465
20110111408
2011-05-12

Methods and composition for secretion of heterologous polypeptides

#466
20110097739
2011-04-28

BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF

#467
20110097392
2011-04-28

ANTIBODY BOUND SYNTHETIC VESICLE CONTAINING MOLECULES FOR DELIVER TO CENTRAL AND PERIPHERAL NERVOUS SYSTEM CELLS

#468
20110064666
2011-03-17

Compound

#469
20110064653
2011-03-17

Class I anti-CEA antibodies and uses thereof

#470
20110044896
2011-02-24

Tumor-targeting monoclonal antibodies to FZD10 and uses thereof

#471
20110033954
2011-02-10

BIOFUNCTIONALIZED QUANTUM DOTS FOR BIOLOGICAL IMAGING

#472
20110027190
2011-02-03

Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label

#473
20110014120
2011-01-20

Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

#474
20110002933
2011-01-06

DR4 ANTIBODIES AND USES THEREOF

#475
20100329983
2010-12-30

COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY

#476
20100316568
2010-12-16

Diagnostic agent and therapeutic agent for pancreatic cancer

#477
20100298672
2010-11-25

METHODS FOR EVALUATING A SUBJECT USING DATA ASSOCIATED WITH A FLUORESCENT ANALYTE

#478
20100234562
2010-09-16

Acute leukemia and lymphoblastic lymphona-specific CD43 epitope

#479
20100196265
2010-08-05

Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof

#480
20100189659
2010-07-29

DIAGNOSTIC SUBSTANCE AND METHOD FOR THE DIAGNOSIS OF PROSTATE DISEASES

#481
20100183636
2010-07-22

ANTI-CD70 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE TREATMENT OF CANCER AND IMMUNE DISORDERS

#482
20100166659
2010-07-01

USE OF CYANINE DYES FOR THE DIAGNOSIS OF PROLIFERATIVE DISEASES

#483
20100158910
2010-06-24

Treatment of renal cell carcinoma with anti-CD70 antibody-drug conjugates

#484
20100150925
2010-06-17

TREATMENT OF B-CELL CANCERS WITH ANTI-CD70 ANTIBODY-DRUG CONJUGATES

#485
20100150829
2010-06-17

Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments

#486
20100119457
2010-05-13

COMPOSITION OF LABELED AND NON-LABELED MONOCLONAL ANTIBODIES

#487
20100104588
2010-04-29

SERUM ALBUMIN BINDING PEPTIDES FOR TUMOR TARGETING

#488
20100093977
2010-04-15

Altered antibodies

#489
20100069616
2010-03-18

ENGINEERED ANTIBODY-NANOPARTICLE CONJUGATES

#490
20100008857
2010-01-14

Hexatriene-β-carbonyl compound

#491
20090324614
2009-12-31

Fc receptor binding proteins

#492
20090317334
2009-12-24

OPTICAL DETECTION METHOD OR IMAGING METHOD OF IMPLANTED CELLS

#493
20090311193
2009-12-17

METHODS AND REAGENTS FOR IN VIVO IMAGING OF CANCER CELL LINES

#494
20090304591
2009-12-10

METHOD AND DEVICE FOR OPTICAL DETECTION OF THE EYE

#495
20090280056
2009-11-12

Antibodies and immunoconjugates and uses therefor

#496
20090233357
2009-09-17

Targeted Delivery of Compounds Using Multimerization Technology

#497
20090220424
2009-09-03

Pro104 antibody compositions and methods of use

#498
20090208411
2009-08-20

Cytotoxicity mediation of cells evidencing surface expression of CD44

#499
20090196831
2009-08-06

Nanostructures, methods of synthesizing thereof, and methods of use thereof

#500
20090181398
2009-07-16

Nanoparticle conjugates

#501
20090180962
2009-07-16

In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes

#502
20090124792
2009-05-14

Fluorescent polymethine cyanine dyes

#503
20090068108
2009-03-12

BIOSPECIFIC CONTRAST AGENTS

#504
20090053247
2009-02-26

Biological materials and uses thereof

#505
20090047300
2009-02-19

BLOOD-BRAIN BARRIER EPITOPES AND USES THEREOF

#506
20090016965
2009-01-15

INTERNAL IMAGE ANTIBODIES FOR OPTICAL IMAGING AND THERAPY

#507
20080305497
2008-12-11

Polymeric carriers for immunohistochemistry and in situ hybridization

#508
20080274049
2008-11-06

Cytotoxicity mediation of cells evidencing surface expression of CD44

#509
20080254499
2008-10-16

Multiphoton in vivo flow cytometry method and device

#510
20080248566
2008-10-09

Matriptase, a serine protease and its applications

#511
20080241861
2008-10-02

Biological materials and methods useful in the diagnosis and treatment of diseases

#512
20080241065
2008-10-02

Systems and methods for the detection and analysis of in vivo circulating cells, entities, and nanobots

#513
20080228049
2008-09-18

Systems, Circuits and Apparatus For In Vivo Detection of Biomolecule Concentrations Using Fluorescent Tags

#514
20080206886
2008-08-28

Large stoke shift dye used for optical imaging

#515
20080206148
2008-08-28

Method for radiographic targeting of malignant tumors and apparatus for focusing rays

#516
20080181965
2008-07-31

Loaded latex optical molecular imaging probes

#517
20080131365
2008-06-05

Cancerous disease modifying antibodies

#518
20080108140
2008-05-08

CEACAM1 mediated protective immunity

#519
20080099728
2008-05-01

Water-Soluble Fluorescent and Production Process Thereof

#520
20080095700
2008-04-24

DR4 antibodies and uses thereof

#521
20080089891
2008-04-17

Cancerous disease modifying antibodies

#522
20080050376
2008-02-28

Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells

#523
20080025989
2008-01-31

ANTI-CD70 ANTIBODY-DRUG CONJUGATES AND THEIR USE FOR THE TREATMENT OF CANCER AND IMMUNE DISORDERS

#524
20070297988
2007-12-27

Optical probes for in vivo imaging

#525
20070202045
2007-08-30

SERUM ALBUMIN BINDING PEPTIDES FOR TUMOR TARGETING

#526
20070172427
2007-07-26

Biofunctionalized quantum dots for biological imaging

#527
20070130632
2007-06-07

Methods for introducing heterologous cells into fish

#528
20070128671
2007-06-07

Monoclonal antibody specific for the extracellular domain of prostate specific membrane antigen

#529
20070110668
2007-05-17

Modulation of immunity and CEACAM1 activity

#530
20070087004
2007-04-19

Pro104 antibody compositions and methods of use

#531
20070072243
2007-03-29

Multiplex screening for lysosomal storage disorders (LSDs)

#532
20070071758
2007-03-29

CEACAM1 based cancer therapy and diagnosis

#533
20070065361
2007-03-22

Ligands to radiation-induced molecules

#534
20070053836
2007-03-08

Cytotoxicity mediation of cells evidencing surface expression of CD44

#535
20070041907
2007-02-22

Immunoglobulin molecules with improved characteristics

#536
20070031428
2007-02-08

Cancerous disease modifying antibodies

#537
20070020179
2007-01-25

Monoclonal antibody specific for CD43 epitope

#538
20070003564
2007-01-04

Diluent for immunohistochemistry

#539
20060281072
2006-12-14

Antibody to the human OX40 receptor

#540
20060275775
2006-12-07

Intramolecularly-quenched near infrared fluorescent probes

#541
20060270919
2006-11-30

Biomarkers sensing

#542
20060246524
2006-11-02

Nanoparticle conjugates

#543
20060239916
2006-10-26

Use of cyanine dyes for the diagnosis of proliferative diseases

#544
20060233794
2006-10-19

Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders

#545
20060216233
2006-09-28

Cytotoxicity mediation of cells evidencing surface expression of CD44

#546
20060216232
2006-09-28

Compositions and methods for the treatment of tumor of hematopoietic origin

#547
20060204435
2006-09-14

Detection, imaging, and depletion of intracellular pathogens

#548
20060199833
2006-09-07

Chemiluminescent compounds and their use

#549
20060160998
2006-07-20

Methods for isolation and purification of fluorochrome-antibody conjugates

#550
20060039863
2006-02-23

Use of cyanine dyes for the diagnosis of disease associated with angiogenesis

#551
20060029547
2006-02-09

Biological materials and methods useful in the diagnosis and treatment of diseases

#552
20060018914
2006-01-26

Novel antibody conjugates reactive with human carcinomas

#553
20050287153
2005-12-29

Serum albumin binding peptides for tumor targeting

#554
20050163711
2005-07-28

Intra-dermal delivery of biologically active agents

#555
20050100542
2005-05-12

Cytotoxicity mediation of cells evidencing surface expression of CD44

#556
20050089471
2005-04-28

Labeled ligands for lectin-like oxidized low-density lipoprotein receptor (LOX-1)

#557
20050049213
2005-03-03

Method for preventing or reversing asthma and compositions useful therefor

#558
20050008646
2005-01-13

Cytotoxicity mediation of cells evidencing surface expression of CD44

#559
20050002865
2005-01-06

Diagnostic/therapeutic agents

#560
17409661
2023-01-24

Tissue-homing peptide conjugates and methods of use thereof

#561
17360855
2022-10-18

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

#562
16838907
2024-06-11

Near infrared small molecule probes for the detection of cellular senescence